| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5269321 | FERRING PHARMS INC | Retrievable pessary |
Jul, 2012
(11 years ago) | |
Cervidil is owned by Ferring Pharms Inc.
Cervidil contains Dinoprostone.
Cervidil has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Cervidil are:
- US5269321
Cervidil was authorised for market use on 30 March, 1995.
Cervidil is available in insert, extended release;vaginal dosage forms.
Cervidil can be used as use as a retrievable pessary.
The generics of Cervidil are possible to be released after 14 July, 2012.
Drugs and Companies using DINOPROSTONE ingredient
Market Authorisation Date: 30 March, 1995
Treatment: Use as a retrievable pessary
Dosage: INSERT, EXTENDED RELEASE;VAGINAL
More Information on Dosage
CERVIDIL family patents
